Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1779-1785

  Olesen, Bente ^a   Hansen, Dennis S ^a   Nilsson, Frida ^a   Frimodt Møller, Jakob ^a,b   Leihof, Rikke Fleron ^b   Struve, Carsten ^b   Scheutz, Flemming ^b   Johnston, Brian ^c   Krogfelt, Karen A ^b   Johnson, James R ^c  

^a HILLERØD HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AEROBACTIN; AGGLUTININ; PROTEINASE; SIDEROPHORE; YERSINIABACTIN;

ALLELE; ARTICLE; BACTERIUM ISOLATE; DANISH; DENMARK; EPIDEMIC; ESCHERICHIA COLI; ETHNIC GROUP; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; VIRULENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DENMARK; EPIDEMICS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PREVALENCE; SEROTYPING; VIRULENCE FACTORS; YOUNG ADULT;

ESCHERICHIA COLI;

EID: 84878519612     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00346-13     Document Type: Article

References (38)

1. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66: 1-14.
2. Peirano G, Pitout JD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents. 35: 316-321.
3. Canton R, Coque TM. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9: 466-475.
4. Partridge SR, Zong Z, Iredell JR. 2011. Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli. Antimicrob. Agents Chemother. 55: 4971-4978.
5. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137:791-797. (Pubitemid 35334450)
6. Orskov F, Orskov I. 1984. Serotyping of Escherichia coli, p 43-112. In Bergan T (ed), Methods in microbiology, vol. 14. Academic Press, London, United Kingdom.
7. Konowalchuk J, Speirs JI, Stavric S. 1977. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18:775-779. (Pubitemid 8247697)
8. Beutin L, Montenegro MA, Orskov I, Orskov F, Prada J, Zimmermann S, Stephan R. 1989. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J. Clin. Microbiol. 27:2559-2564. (Pubitemid 19251807)
9. Lester CH, Olsen SS, Jakobsen L, Arpi M, Fuursted K, Hansen DS, Heltberg O, Holm A, Hojbjerg T, Jensen KT, Johansen HK, Justesen US, Kemp M, Knudsen JD, Roder B, Frimodt-Moller N, Hammerum AM. 2011. Emergence of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand. Int. J. Antimicrob. Agents. 38: 180-182.
10. Cortes P, Blanc V, Mora A, Dahbi G, Blanco JE, Blanco M, Lopez C, Andreu A, Navarro F, Alonso MP, Bou G, Blanco J, Llagostera M. 2010. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 76: 2799-2805.
11. Dhanji H, Doumith M, Clermont O, Denamur E, Hope R, Livermore DM, Woodford N. 2010. Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamases. Int. J. Antimicrob. Agents. 36: 355-358.
12. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53: 2733-2739.
13. Johnson JR, Owens K, Manges AR, Riley LW. 2004. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J. Clin. Microbiol. 42:2618-2622. (Pubitemid 38747512)
14. Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB. 2006. Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect. 8:1702-1713. (Pubitemid 44128872)
15. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272. (Pubitemid 30049057)
16. Johnson JR, Stell AL, Scheutz F, O'Bryan TT, Russo TA, Carlino UB, Fasching C, Kavle J, Van Dijk L, Gaastra E. 2000. Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect. Immun. 68:1587-1599. (Pubitemid 30108562)
17. Johnson JR, Murray AC, Gajewski A, Sullivan M, Snippes P, Kuskowski MA, Smith KE. 2003. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 47:2161-2168. (Pubitemid 36753567)
18. Johnson JR, O'Bryan TT. 2004. Detection of the Escherichia coli group 2 polysaccharide capsule synthesis Gene kpsM by a rapid and specific PCR-based assay. J. Clin. Microbiol. 42:1773-1776. (Pubitemid 38500837)
19. Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, Kotloff KL, Levine MM, Sow S, Tamboura B, Toure A, Malle D, Panchalingam S, Krogfelt KA, Nataro JP. 2012. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J. Infect. Dis. 205: 431-444.
20. Clermont O, Johnson JR, Menard M, Denamur E. 2007. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn. Microbiol. Infect. Dis. 57:129-136. (Pubitemid 46135872)
21. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppe E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64: 274-277.
22. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3: 59-67.
23. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33: 2233-2239.
24. Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, Alfa M, Pienaar C, Kibsey P, Pitout JD. 2010. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 54: 1327-1330.
25. Coelho A, Mora A, Mamani R, Lopez C, Gonzalez-Lopez JJ, Larrosa MN, Quintero-Zarate JN, Dahbi G, Herrera A, Blanco JE, Blanco M, Alonso MP, Prats G, Blanco J. 2011. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 66: 517-526.
26. CTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56: 2364-2370.
27. Nielsen JB, Albayati A, Jorgensen RL, Hansen KH, Lundgren B, Schonning K. 2013. An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum beta-lactamase-producing lineage in the Copenhagen area. Eur. J. Clin. Microbiol. Infect. Dis. 32: 431-436.
28. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A, Norwegian ESBL Study Group. 2009. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 117: 526-536.
29. Kudinha T, Kong F, Johnson JR, Andrew SD, Anderson P, Gilbert GL. 2012. Multiplex PCR-based reverse line blot assay for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli. Appl. Environ. Microbiol. 78: 1198-1202.
30. Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S, on behalf of the Kyoto-Shiga Clinical Microbiology Study Group. 2012. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-beta-lactamase-producing Escherichia coli in Japan. J. Antimicrob. Chemother. 67: 2612-2620.
31. Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A. 2011. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J. Antimicrob. Chemother. 66: 2501-2508.
32. Johnson JR, Murray AC, Kuskowski MA, Schubert S, Prere MF, Picard B, Colodner R, Raz R, Trans-Global Initiative for Antimicrobial Resistance Initiative (TIARA) Investigators. 2005. Distribution and characteristics of Escherichia coli clonal group A. Emerg. Infect. Dis. 11:141-145. (Pubitemid 40093371)
33. Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. 2005. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 49:4667-4670. (Pubitemid 41552598)
34. Tartof SY, Solberg OD, Manges AR, Riley LW. 2005. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J. Clin. Microbiol. 43:5860-5864. (Pubitemid 43100629)
35. Olesen B, Scheutz F, Menard M, Skov MN, Kolmos HJ, Kuskowski MA, Johnson JR. 2009. Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J. Clin. Microbiol. 47: 1857-1862.
36. Colomer-Lluch M, Mora A, Lopez C, Mamani R, Dahbi G, Marzoa J, Herrera A, Viso S, Blanco JE, Blanco M, Alonso MP, Jofre J, Muniesa M, Blanco J. 7 December 2012. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain. J. Antimicrob. Chemother. doi:10.1093/jac/ dks477.
37. Olesen B, Scheutz F, Andersen RL, Menard M, Boisen N, Johnston B, Hansen DS, Krogfelt KA, Nataro JP, Johnson JR. 2012. Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract Infection. J. Clin. Microbiol. 50: 3703-3711.
38. Boll EJ, Struve C, Olesen B, Stahlhut SG, Krogfelt KA. 28 January 2013. Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect. Immun. doi:10.1128/IAI.01376-12.